Thank you for the submission of your manuscript to EMBO reports. I am sorry for the slight delay in getting back to you, but we have only now received the full set of referee reports that is copied below.
Thank you for the submission of your manuscript to EMBO reports. I am sorry for the slight delay in getting back to you, but we have only now received the full set of referee reports that is copied below.
As you will see, all referees agree that the findings are potentially interesting and novel. However, both referees 2 and 3 list a number of controls that are missing in order to exclude artifacts and to strengthen the conclusions. After cross-commenting on each others reports, referee 1 agreed that the concerns of referee 2 are valuable. I therefore suggest that you concentrate on experimentally addressing these concerns, while all other comments should be addressed at least in the point-bypoint response. If referee 2 can be convinced by the revised data, we can offer to publish your manuscript.
Acceptance of the manuscript will depend on a positive outcome of a second round of review. It is EMBO reports policy to allow a single round of revision only and acceptance or rejection of the manuscript will therefore depend on the completeness of your responses included in the next, final version of the manuscript.
Revised manuscripts should be submitted within three months of a request for revision; they will otherwise be treated as new submissions. Also, the revised manuscript may not exceed 30,000 characters (including spaces and references) and 5 figures plus 5 supplementary figures, which should directly relate to their corresponding main figure.
The current character count largely exceeds our limits, and the revised manuscript therefore needs to be shortened. While parts of the materials and methods can be moved to the supplement, basic materials and methods essential to understanding the experiments described in the main body of the manuscript may not be presented in the supplementary information. We do offer the possibility of combining the results and discussion into a single section. This may help to eliminate some redundancy that is inevitable when discussing the same experiments twice.
Can I also ask you to please include scale bars in the microscope images (figure 4, SF1A, 2A).
When submitting your revised manuscript, please include:
A Microsoft Word file of the manuscript text, editable high resolution TIFF or EPS-formatted figure files, a separate PDF file of any Supplementary information (in its final format), a letter detailing your responses to all the referee comments, and a two sentence summary of your findings and their significance.
We also recently decided to offer the authors the possibility to submit "source data" with their revised manuscript that will be published in a separate supplemental file online along with the accepted manuscript. If you would like to use this opportunity, please submit the source data (for example entire gels or blots, data points of graphs, additional images, etc.) of your key experiments together with the revised manuscript.
We would also welcome the submission of cover suggestions, or motifs to be used by our Graphics Illustrator in designing a cover.
As part of the EMBO publication's Transparent Editorial Process, EMBO reports publishes online a Review Process File to accompany accepted manuscripts. This File will be published in conjunction with your paper and will include the referee reports, your point-by-point response and all pertinent correspondence relating to the manuscript.
You are able to opt out of this by letting the editorial office know (emboreports@embo.org). If you do opt out, the Review Process File link will point to the following statement: "No Review Process File is available with this article, as the authors have chosen not to make the review process public in this case." I look forward to seeing a revised version of your manuscript when it is ready.
REFEREE REPORTS:
Referee #1:
Despite intense attention, we remain largely ignorant of the mechanisms underlying the function of chromatin insulators. One reason for this unfortunate situation is that that involved molecular players have not been fully elucidated. The manuscript authored by Matzat, Dale and Lei is a point in case. Here the authors make the case for that Drosophila chromatin insulators require RNA components. Conceptually this is not an entirely new observation, as it has earlier been demonstrated that non-coding RNA (SRA) binds to p68 which frms a complex with the mammalian version of CTCF-dependent chromatin insulators. What is very surprising in this study is that the Drosophila RNA components encode transcripts encoding members of the insulator complex itself, i.e. su(Hw) and Cp190. Given the natural suspicion that this could reflect a cytoplasmic contamination issue, the authors showed absence of ribosomal components. Other controls, notably the use of RIP analysis of the dl transcript seem to rule out a fortitious presence of su(Hw) and Cp190 mRNAs at chromatin insulators. A very important experiment addressed the functional consequences of the presence of these transcripts at chromatin insulators. Using engineered constructs to produce su(Hw) and Cp190 transcripts that could not give rise to corresponding proteins, the authors could show that not only was the chromatin insulator function improved, but also that the insulator bodies appeared more pronounced and numerous. Importantly, a control RNA encoding the mod(mdg4)2.2 transcript did not produce a similar effect.
I find this manuscript both novel and interesting thus deserving rapid publication. The results will likely reflect that the chromatin insulator complex involves specific transcripts to facilitate the formation of insulator bodies and enhance their function. My only slightly negative comment would be that the story would have been more complete would the effects of the su(Hw) and Cp190 transcripts been mapped to particular regions. I do realize that such an endeavor represents hard work and perhaps represent more part a follow-up story.
Referee #2:
Chromatin insulation in the context of the Su(Hw) and CP190 proteins has been previously shown to involve RNA. The authors studied the nature of the RNA molecules involved and claimed that the full-length Su(Hw) and CP190 coding mRNAs are associated with these proteins. Such a result would be a novel feature of chromatin organizing proteins being associated with their own mature mRNA. Because of its impact, such a finding requires careful validation and controls, which unfortunately are missing. 1. The experimental strategy to identify RNA molecules associated with the insulator factors involved sequential purification of RNA/protein complexes with antibodies against Su(w) and against CP190. Subsequent RNA purification identified bands between 35 and 55nt in length. Sequencing of this material identified Su(Hw)-and CP190-mRNA fragments corresponding to the full-length mature mRNA. This could easily be explained by a contamination in the lab with RNA from expression plasmids and therefore needs rigorous validation. Such a validation should involve the same purification procedure and RT-PCR with primers covering several Su(Hw) and CP190 exons (positive), several introns (negative) and other genes. The only validation attempt I found was just a Su(Hw) precipitation (no sequential CP190 ppt) and RT-PCR with a single primer pair for Su(Hw), i.e. the major conclusion derived from Fig. 1 that full-length and spliced Su(Hw)-and CP190-mRNA are associated with these insulator factors, is not validated. 2. In figure 2 the same sequential Su(Hw) and CP190 purification was used, but followed by an oligdT selection. This procedure identified again Su(Hw)-and CP190-mRNA in addition to 7 other transcripts. Apparently, there was no degradation to 35-55nt, otherwise it should not be possible to purify polyA-plus RNA. With this new procedure we do not know, whether again a similar exon-specific and full-length coverage as in Fig. 1 (C, D) is observed. A comparable Figure should be generated. Also, for the other RNAs coding for "chromatin function", the sequence coverage as depicted in Fig.  1 (C, D) has to be shown for the reader to judge, whether again full-length spliced mRNAs are bound. Interestingly, this has been shown for the negative control (Fig. 3) , demonstrating clearly that RNA coverage does not depict the full length spliced mRNA. 3. To test for functional effects by the RNA molecules the authors produced T7 polymerase generated transcripts. Theoretically, such transcripts should not be translated and indeed, western analysis of Su(Hw) and of CP190 did not show gross changes in protein amounts (Fig. 4C) . Unfortunately, only the bands of the full-length proteins in the western blots are shown. Irregular processing and translation pathways could result in functional protein fragments. Therefore, the western lanes from top to bottom have to be presented. 4. One of the functional tests involved the analysis of insulator speckles within the nuclei. The micrographs shown suggest a single speckle in wt cells and in negative controls, whereas in Su(Hw)-or CP190-T7RNA expressing cells two to three speckles are pointed out (Fig. 4D ). This has to be evaluated by counting a relevant number of nuclei.
Referee #3: THE PAPER This manuscript describes new and rather disconcerting findings on the constituents of the gypsy chromatin insulator complex. If these observations hold true, they are of great potential and interest. Using antibodies directed against 2 constituents of the gypsy insulator [αSu(Hw) and αCP190], the authors purify gypsy insulator complexes by double chromatin IP and then sequence the RNA fraction associated with the purified material. Strikingly, they observe high enrichment into mRNA sequences encoding both Su(Hw) and CP190. In order to test the functional relevance of this observation, the authors have generated fly trains that over-express untranslatable Su(HW) and CP190 mRNA sequences. The idea behind this scheme is that if these mRNA sequences play a role in the formation of the gypsy chromatin insulator complexes, increasing their level of expression may modify the kinetic of complex formation or interfere with complex functions. To test for the functionality of the gypsy chromatin complexes, the authors used 2 in-vivo assays. One assay is cytological, by looking directly at the formation of insulator bodies in cells from imaginal discs. In the second assay (functional), the authors use a particular "cut" allele, in which the remote enhancer regulating "cut" expression in the wing is prevented from regulating properly the "cut" promoter, by an interfering gypsy insulator. The particularity in this "cut" allele (ct6) is that the gypsy is only partially blocking the wing enhancer, providing thus an assay where one can score for enhancement or suppression of insulation. With these assays, the authors find that T7 mediated expression of Su(Hw) mRNA affects insulator body formation and enhances gypsy insulation of ct6. In the case of T7-mediated expression of CP190 the effects are reported to be milder on both insulation body aspect (see comment below) and enhancer-blocking of the ct6 allele.
COMMENTS The recovery of the messenger RNAs encoding the proteins against which the antibodies used to perform the complex purification were directed is a conspicuous coincidence. One is obviously concerned about the possibility of a contamination by translating polysomes. The authors also consider the possibility that any chromatin-associated protein would copurify its own coding transcript in their purification protocol. To rule out these possible caveats the authors performed a control IP using an antibody directed against the transcription factor Dorsal. While I congratulate the authors for performing a control, I believe that the choice of Dorsal is not optimal because Dorsal is encoded by a maternal mRNA source that is translated only during the 1st few hours of embryogenesis. Given the fact that the egg collection was performed over a period of 24 hours, and depending at which time of the day, the egg plate was removed from the cage there may well be no early embryos and no more possible contaminating Dl-translating polysomes in the extracts. It would have been much better to use a control gene expressed both maternally and zygotically at levels similar to Su(Hw) or CP190. I am also concerned by the fact that the authors needed to control that chromatin-associated protein would copurify its own coding transcript in their purification protocol. If that was true, given the high number of Su(Hw) and CP190 targets sites in the genome they should recover many more enriched transcripts, and there would be no reasons for recovering only Su(Hw) and CP190. Furthermore, these recovered reads should be from nascent transcripts and not mature mRNAs. In fact the authors acknowledge the recovery of nascent transcripts from the Dl fraction. In summary I find the logic misleading. If the in vivo observations described in the second part of the paper were solid state data, I would give the benefit of the doubt regarding a possible polysome contamination. However this is far from being the case, and I am therefore inclined to think that the Dl control is not a good choice.
The in vivo data are far from being convincing. First I am not sure to understand what insulator bodies mean on the basis of the data reported in Fig4D. The authors claim that T7 mediated Su(Hw) overexpression lead to the formation of ectopic bodies. There are indeed more discrete spots in those nuclei of the leg disc, but the overall CP190 fluorescence is less intense than in the WT leg disc cells. Does this mean that there are additional bodies. It could be that in the WT cells the higher CP190 staining mask these discrete spots. Also the authors claim that T7 mediated expression of CP190 has a weaker effect than the effect mediated by Su(Hw). This is clearly not the case in the leg disc, where I see no difference. I agree that the CP190 effect is weaker in the eye imaginal disc cells.
I suspect that the authors are inclined to conclude for a weaker effect of CP190 because it corresponds to the observations made in the wing with the enhancer-blocking assay. But is there any correlation between the aspect of insulator bodies and enhancer-blocking? To me this not clear and without a correlation, the insulator body aspect is not a very convincing argument. Perhaps, the most interesting evidences comes from the enhancer-blocking activity assay where a genetic interaction is observed between T7 mediated production of the Su(Hw) mRNA and the ct6 phenotype. However this experiment is poorly explained with discrepancies between the text in the result section and the Figure 4 legend, which makes it very difficult to understand. One problem arises from the fact that expression of the T7 polymerase alone using the Serate-Gal4 drivers already causes blistering and necrosis of the wing (as mentioned in the result section). Given the fact that the ct6 phenotype is scored by wing blistering, it is hard to understand how much of the phenotype is contributed by T7 polymerase expression alone and how much is brought by ct6. The proper way to compare the severity of wing blistering in the background of ct6 and mod (mdg44)u1 is to show wings with T7 alone next to wings of the same genotype plus the UAS-Su(Hw) (or UAS-CP190) (as they did in the disc cells in the insulator body experiment). Without this proper control experiments, I am afraid that the experiment is not conclusive. Also, the fact that T7 expression alone is deleterious to the viability of the fly suggests that transcription may fire from cryptic promoters, interfering with expression of adjacent genes. It is thus very important to have the proper controls for the backgrounds. In this respect, it would have been much better to express the UASSu(Hw) and UAS-CP190 from the same genomic platforms with the help of the phiC31 integration system.
The possibility that the mRNA of Su(Hw) and CP190 play a role into the establishment of a functional gypsy insulator complex is very unexpected. If these observations proved to be true, they would definitively bring a new and unexpected layer of complexity into the field transcriptional and post-transcriptional regulation. However this study suffers of too many caveats to be published in this form.
Response to Editor and Referees
We greatly appreciate the enthusiasm from the Referees for our novel findings and the opportunity to revise the manuscript. We performed all of the experiments suggested by Referee #2, and addressed all of the Referees' concerns. Specifically, we added quantitative RT-PCR of exon versus intron sequences to verify the directional Su(Hw)/CP190 RIP findings of Fig 1. We also added screenshots to further demonstrate that we purify full-length, spliced transcripts. Furthermore, we repeated Western blotting to show that aberrant protein products are not made as a result of T7 transcript expression. Finally, we added quantitation and statistical analysis of insulator bodies in Fig 4. As a result of these revisions, the manuscript is much improved. Please find a detailed list of our responses to the Editor's and Referees' comments below. Editor Also, the revised manuscript may not exceed 30,000 characters (including spaces and references) and 5 figures plus 5 supplementary figures, which should directly relate to their corresponding main figure….We do offer the possibility of combining the results and discussion into a single section. This may help to eliminate some redundancy that is inevitable when discussing the same experiments twice. In order to achieve the required character limit, we have made numerous text edits including combining the Results and Discussion as well as trimming unnecessary text from all sections. Our revised manuscript contains 4 figures plus 5 supplementary figures, which relate directly to the main figures. Can I also ask you to please include scale bars in the microscope images (figure 4, SF1A, 2A). We added scale bars to the images in Fig 4 and Fig S1A. There is no microscope image in Fig 2A. Referee #1 I find this manuscript both novel and interesting thus deserving rapid publication. We highly appreciate the enthusiasm communicated by Referee #1 as well as his/her willingness to cross-comment on the other Referees' reports. My only slightly negative comment would be that the story would have been more complete would the effects of the su(Hw) and Cp190 transcripts been mapped to particular regions. I do realize that such an endeavor represents hard work and perhaps represent more part a follow--up story. We absolutely agree that mapping the required sequences of the su(Hw) and Cp190 transcripts is an essential future experiment and now point this out on p. 11 of the conclusion. Unfortunately, as the reviewer acknowledged, this endeavor will require a great deal of time and effort because of the need to clone all of the constructs, generate the transgenic lines, and perform all of controls and analyses. Thus far, we have been able to show that T7 expression of a su(Hw) transcript lacking the 3' UTR is sufficient to cause mislocalization of insulator bodies similar to the full length transcript, while the 3' UTR sequence alone is not capable. These experiments are just the beginning of the mapping experiments but at least provide preliminary evidence that sequence specificity does exist. Referee #2 1. The experimental strategy to identify RNA molecules associated with the insulator factors involved sequential purification of RNA/protein complexes with antibodies against Su(w) and against CP190. Subsequent RNA purification identified bands between 35 and 55nt in length. Sequencing of this material identified Su(Hw)--and CP190--mRNA fragments corresponding to the full--length mature mRNA. This could easily be explained by a contamination in the lab with RNA from expression plasmids and therefore needs rigorous validation. It is somewhat unclear to us what the specific concern of this reviewer may be, but we address the most likely interpretations below.
Interpretation 1: The laboratory is contaminated with su(Hw) and Cp190 RNA from large scale, full-length in vitro transcription experiments.
We have never performed such experiments in our laboratory. We have only performed in vitro transcription of fragments of these cDNAs in PCR product templates using T7 RNA polymerase, which could not be the source of full-length su(Hw) or Cp190 sequence coverage present in our Su(Hw)/CP190 RIP libraries.
Interpretation 2: The laboratory is contaminated with su(Hw) and Cp190 RNA produced by bacteria used for plasmid purification.
We have strong evidence for enrichment of polyadenylated su(Hw) and Cp190 transcripts in our oligo-dT purifications, which could not be synthesized by E. coli. See also response to Interpretation 3, starting at the second paragraph (*)
Interpretation 3: The laboratory is contaminated with su(Hw) and Cp190 cDNAcontaining plasmids purified in the laboratory.
All of our RNA libraries are DNase I treated before reverse transcription followed by cloning or RT-PCR, and minus RT controls result in no detectable signal for su (Hw) or Cp190. This is now indicated in the Fig 2C legend. * We have prepared a variety of plasmids in our laboratory, including constructs that encode Drosophila cDNAs such as mod(mdg4)2.2, which we have not identified as enriched in our RNA immunopurifications. It is hard to imagine how, among these many plasmids, only su(Hw) or Cp190 sequences would specifically contaminate our IP and not preimmune or input samples. Because we regularly work with small amounts of RNA that are highly sensitive to degradation, we perform our plasmids preps on benches separate from our usual work areas and use only disposable plastics as well as dedicated pipets with aerosol-filtered tips for this purpose. We also routinely use aerosol-filtered tips and clean disposable plastics for all of our RNA work. Such a validation should involve the same purification procedure and RT--PCR with primers covering several Su(Hw) and CP190 exons (positive), several introns (negative) and other genes. The only validation attempt I found was just a Su(Hw) precipitation (no sequential CP190 ppt) and RT--PCR with a single primer pair for Su(Hw), i.e. the major conclusion derived from Fig. 1 that full--length and spliced Su(Hw)--and CP190--mRNA are associated with these insulator factors, is not validated. We additionally validated the findings in Fig 1 that spliced, full-length transcripts were purified by performing RIP from embryonic nuclear extracts using preimmune or antiSu(Hw) antibodies. This was followed by DNase I treatment as usual, and gene-specific quantitative RT-PCR for su(Hw) and Cp190 by priming using 3' UTR sequence instead of oligo-dT. The PCR step utilizes two independent sets of primers within one exon, spanning an exon-intron region, or located in two adjacent exons. The results are now shown in Fig S1 and indicate that only exon sequences are enriched in the IP versus preimmune sample and that nascent/intron sequence is only present at very low levels in both samples. Minus RT controls resulted in immeasurably low values. As stated in the text on p. 6, sufficient amounts of anti-CP190 antibody are no longer available to repeat the sequential immunoaffinity purification 2. In figure 2 the same sequential Su(Hw) and CP190 purification was used, but followed by an olig--dT selection. This procedure identified again Su(Hw)--and CP190--mRNA in addition to 7 other transcripts. Apparently, there was no degradation to 35--55nt, otherwise it should not be possible to purify polyA--plus RNA. Although the oligo-dT selection protocol is simpler than the gel purification procedure, it would seem likely that at least some degradation would also occur during this still lengthy procedure. However, we did not attempt to monitor the relative level of degradation in either experiment. In the gel purification protocol, we suspect that there is a significant amount of full-length transcript that remains in the well of the high percentage polyacrylamide gel.
With this new procedure we do not know, whether again a similar exon--specific and full--length coverage as in Fig. 1 (C, D) is observed. A comparable Figure should be generated. Also, for the other RNAs coding for "chromatin function", the sequence coverage as depicted in Fig. 1 (C, D) has to be shown for the reader to judge, whether again full--length spliced mRNAs are bound. Interestingly, this has been shown for the negative control (Fig. 3) , demonstrating clearly that RNA coverage does not depict the full length spliced mRNA. We added as Fig S2 screenshots that show su(Hw) , Cp190, the seven additional genes for which transcripts were enriched in the Su(Hw)/CP190 RIP in Fig 2 as well as two negative control genes, dl and RpL32. As would be expected from oligo-dT purified material, which should not be nascent, these screenshots clearly show lack of immunoprecipitated intron sequence or 3' extensions. 3. To test for functional effects by the RNA molecules the authors produced T7 polymerase generated transcripts. Theoretically, such transcripts should not be translated and indeed, western analysis of Su(Hw) and of CP190 did not show gross changes in protein amounts (Fig. 4C) . Unfortunately, only the bands of the full--length proteins in the western blots are shown. Irregular processing and translation pathways could result in functional protein fragments. Therefore, the western lanes from top to bottom have to be presented. We added as Fig S3 new Western blots using the same lysates run in Fig 4C that are probed for the entirety of the gel. Aside from minor non-specific signal from the antisera in each of the lanes, no irregular protein sizes or fragments are observed as a result of T7 expression. Ponceau S staining of the membrane before blotting is shown as a control for loading and transfer. 4. One of the functional tests involved the analysis of insulator speckles within the nuclei. The micrographs shown suggest a single speckle in wt cells and in negative controls, whereas in Su(Hw)--or CP190--T7RNA expressing cells two to three speckles are pointed out (Fig. 4D) . This has to be evaluated by counting a relevant number of nuclei. We added as Fig 4E statistical analysis of ≥ 101 nuclei from at least five representative fields corresponding to Fig 4D for each genotype . The results show highly significant differences (p < 1.0 x 10 -10 , Kruskal-Wallis test) between the control and T7-su(Hw) or T7-Cp190 but no significant difference between the control and T7-mod(mdg4)2.2 in the legs and no significant differences for all genotypes compared to control in the eyes. In the leg, the median number of insulator bodies per nucleus in the control or T7-mod(mdg4)2.2 is 1 while the median for T7-su(Hw) and T7-Cp190 genotypes is 3. In the eye, all genotypes show a median number of 1 insulator body per nucleus. Referee #3 Using antibodies directed against 2 constituents of the gypsy insulator [αSu(Hw) and αCP190], the authors purify gypsy insulator complexes by double chromatin IP and then sequence the RNA fraction associated with the purified material.
The referee is incorrect that the sequential immunoaffinity column purification procedure is a "double chromatin IP". As described in the Supplementary Methods, these native purifications were performed on soluble nuclear extract. No crosslinking was performed in this study, with the intent of recovering only highly stable RNA interactions. The recovery of the messenger RNAs encoding the proteins against which the antibodies used to perform the complex purification were directed is a conspicuous coincidence. One is obviously concerned about the possibility of a contamination by translating polysomes. As stated on p. 8, mass spectrometry results from similar anti-CP190 complex purifications as described in Lei and Corces, 2006 did not detect the presence of ribosomal proteins. The authors also consider the possibility that any chromatin--associated protein would copurify its own coding transcript in their purification protocol. To rule out these possible caveats the authors performed a control IP using an antibody directed against the transcription factor Dorsal. While I congratulate the authors for performing a control, I believe that the choice of Dorsal is not optimal because Dorsal is encoded by a maternal mRNA source that is translated only during the 1st few hours of embryogenesis. Given the fact that the egg collection was performed over a period of 24 hours, and depending at which time of the day, the egg plate was removed from the cage there may well be no early embryos and no more possible contaminating Dl--translating polysomes in the extracts. It would have been much better to use a control gene expressed both maternally and zygotically at levels similar to Su(Hw) or CP190. The referee is correct that dl transcript is maternally deposited and translated in the early embryo, which likely constitutes a small fraction of the embryos collected for complex purification. However, dl is also expressed in the embryo after the clearing of maternal transcript and the onset of zygotic transcription starting at stage 11 (around 6 h after egg laying) and at approximately the same levels as the maternal deposit, remaining expressed even into the adult stage (Gross et al., 1999 and Graveley et al., 2011) . We agree that dl transcript appears to be expressed at a lower level than su(Hw) and Cp190 transcripts (Graveley et al., 2011); however, there is no evidence to suggest that the relative fraction of transcript undergoing translation at any given time differs from that of su(Hw) and Cp190. As explained on p. 7, we chose Dorsal as a negative control RIP because of the availability of ChIP grade antibodies, the fact that it is a well-studied, highly expressed transcription factor with a known genome-wide binding profile, has no known capacity to bind RNA, and has no known physical or functional relationship with chromatin insulator complexes. I am also concerned by the fact that the authors needed to control that chromatin--associated protein would copurify its own coding transcript in their purification protocol. If that was true, given the high number of Su(Hw) and CP190 targets sites in the genome they should recover many more enriched transcripts, and there would be no reasons for recovering only Su(Hw) and CP190. Furthermore, these recovered reads should be from nascent transcripts and not mature mRNAs. In fact the authors acknowledge the recovery of nascent transcripts from the Dl fraction. In summary I find the logic misleading. It is unclear why the referee is concerned that we chose to perform a highly rigorous negative control to dispel obvious suspicion about a potential experimental artifact. We interpret this statement to mean that the referee questions why the sequential Su(Hw)/CP190 RIP does not pull down nascent transcripts in the vicinity of insulator binding sites, which occurs in the Dorsal RIP. We surmise that in the Dorsal RIP, since Dorsal does not stably associate with any particular RNA in vivo, that the only RNAs that are detectably enriched are the nascent transcripts nearby binding sites in chromatin. We have no insight as to why this phenomenon occurs; perhaps Dorsal is "sticky" or we are purifying regions of transcribing chromatin. As stated on p. 8, we suppose that the larger number of statistically significant associated transcripts in the Dl RIP compared to the sequential Su(Hw)/CP190 RIP is due to higher consistency of purification across biological replicates due to the relatively simpler purification protocol (~ 7 h to obtain purified RNA, not including cloning steps). Because the Su(Hw)/CP190 sequential immunoaffinity purification is lengthy (>12 h for oligo-dT) and requires more extensive manipulation of samples, the resulting material varies more across biological replicates. DESeq analysis incorporates variance into statistical tests, thus less sensitivity can be achieved in the sequential Su(Hw)/CP190 RIP experiment. It therefore seems unlikely that low levels of nascent transcripts proximal to DNA-bound chromatin insulator complexes would be detected by this procedure; only the most highly enriched transcripts pass the stringent p adj < 0.02 threshold of statistical significance. These full-length, spliced mRNAs purified in sequential Su(Hw)/CP190 RIP do not necessarily correspond to insulator complex binding sites and likely correspond to a distinct population that merits further study. The in vivo data are far from being convincing. First I am not sure to understand what insulator bodies mean on the basis of the data reported in Fig4D. The authors claim that T7 mediated Su(Hw) overexpression lead to the formation of ectopic bodies. There are indeed more discrete spots in those nuclei of the leg disc, but the overall CP190 fluorescence is less intense than in the WT leg disc cells. Does this mean that there are additional bodies. It could be that in the WT cells the higher CP190 staining mask these discrete spots. We revised the text on p. 10 to read "Compared to no T7 transcript or T7-mod(mdg4)2.2 expression using Ser::Gal4, T7-su(Hw) causes formation of ectopic and more pronounced insulator bodies relative to overall nucleoplasmic signal particularly in peripheral cells of the leg discs…" We agree with the referee that the distribution of nuclear signal is more concentrated in insulator bodies in T7-su(Hw) expressing cells compared to no T7 transcript, and this effect may create the illusion of a difference in overall levels. Based on western blotting in Fig 4C, which is more quantitative than immunofluorescence, there is no evidence that the overall level of CP190 differs across the control and experimental cells. The statistical analysis of the number of insulator body foci per nucleus per genotype and tissue type are now presented in Fig 4E. Also the authors claim that T7 mediated expression of CP190 has a weaker effect than the effect mediated by Su(Hw). This is clearly not the case in the leg disc, where I see no difference. We revised the text on p. 10 to "Expression of T7-Cp190 causes a less penetrant and less pronounced but similar phenotype to T7-su(Hw) (observed in 4 of 7 experiments)." Our assessment is based on the fact that mislocalization is observed in T7-Cp190 expressing cells less consistently across biological replicates than what is observed for T7-su(Hw) compared to the control. Furthermore, the intensity of insulator bodies relative to intranuclear signal appears lower in T7-Cp190 compared to T7-su(Hw) expressing cells. We agree with the reviewer that there is no statistically significant difference in the number of foci in T7-Cp190 compared to T7-su(Hw) expressing cells in either the leg or eye disc as now shown in Fig 4E. I agree that the CP190 effect is weaker in the eye imaginal disc cells. As stated on p. 10, we do not observe a difference in insulator body localization in T7-su(Hw) or T7-Cp190 expressing eye disc cells compared to the control. These results are now quantified in Fig 4E. I suspect that the authors are inclined to conclude for a weaker effect of CP190 because it corresponds to the observations made in the wing with the enhancer--blocking assay. But is there any correlation between the aspect of insulator bodies and enhancer--blocking? To me this not clear and without a correlation, the insulator body aspect is not a very convincing argument. As explained above, we do observe less consistent effects across biological replicates, each sample of which corresponds to a group of approximately five to six individual larvae, with respect to changes in overall insulator body localization in T7-Cp190 expressing cells compared to T7-su(Hw) expressing cells as indicated on p. 10. This result indeed correlates with their respective effects on the ct 6 enhancer blocking phenotype. Perhaps, the most interesting evidences comes from the enhancer--blocking activity assay where a genetic interaction is observed between T7 mediated production of the Su(Hw) mRNA and the ct6 phenotype. However this experiment is poorly explained with discrepancies between the text in the result section and the Figure 4 legend, which makes it very difficult to understand. We revised the text and Fig 4F legend for improved clarity. One problem arises from the fact that expression of the T7 polymerase alone using the Serate--Gal4 drivers already causes blistering and necrosis of the wing (as mentioned in the result section). Given the fact that the ct6 phenotype is scored by wing blistering, it is hard to understand how much of the phenotype is contributed by T7 polymerase expression alone and how much is brought by ct6. The referee is incorrect that the ct 6 phenotype is scored by wing blistering. This classic enhancer blocking assay is scored based on the morphology of the wing margin as shown in Fig 4F. A more jagged wing margin corresponds to a decrease in ct 6 expression, which suggests increased insulator activity. In fact, wing blistering precludes scoring of the wing margin, which is why genotypes that display extensive wing blistering (described in detail in Fig S4) could not be reliably scored for the ct 6 phenotype. The proper way to compare the severity of wing blistering in the background of ct6 and mod (mdg44)u1 is to show wings with T7 alone next to wings of the same genotype plus the UAS--Su(Hw) (or UAS--CP190) (as they did in the disc cells in the insulator body experiment). Without this proper control experiments, I am afraid that the experiment is not conclusive. As previously stated, wing blistering precludes scoring of the wing margin, which is why genotypes that display extensive wing blistering could not be reliably scored for the ct 6 phenotype. Given this technical limitation, we performed an alternate comparison of the phenotype of ct 6 in flies plus or minus T7 polymerase expression by Ser::Gal4. These genotypes display lower levels of wing blistering, as indicated in Fig S4, and can more reliably be scored for the ct 6 phenotype. Also, the fact that T7 expression alone is deleterious to the viability of the fly suggests that transcription may fire from cryptic promoters, interfering with expression of adjacent genes. It is thus very important to have the proper controls for the backgrounds. We agree that it would be ideal to perform the control as suggested, but as previously stated, wing blistering precludes scoring of the wing margin, which is why genotypes that display extensive wing blistering could not be reliably scored for the ct 6 phenotype. In this respect, it would have been much better to express the UAS--Su(Hw) and UAS--CP190 from the same genomic platforms with the help of the phiC31 integration system. As stated in the Supplementary Methods, at least two independent genomic insertions for each T7 construct were scored and verified to produce similar results. We first selected insertions based on similar transgene reporter eye colors that were then verified to express T7 transcripts at similar levels by RT-PCR. Thank you for the submission of your revised manuscript to our journal. We have now received the enclosed reports from the referees that were asked to assess it.
As you will see, referee 3 is still concerned that T7 toxicity may confound the in vivo enhancer blocking phenotypes and is asking for several more controls. After cross-commenting on referee 3's report, referee 2 agrees that some of these controls should be provided (please see below). I therefore think that this last concern needs to be addressed, and I would like to give you the exceptional opportunity to do so, along the lines suggested by referee 2.
Referee 2 also remarks that the statements on full length mRNA transcripts need to be turned down.
Can you please add a scale bar to figure 4F, SF 4C and SF 5A? Thank you.
I look forward to seeing a new revised version of your manuscript as soon as possible.
REFREE REPORTS:
The surprising claim of the first version of this manuscript was that the insulator protein complex with the Su(Hw) and CP190 protein components stably associates with full length spliced and polyadenylated mRNA coding for exactly these two proteins. Such a statement includes two parts. First, RNA sequences coding for these factors are bound and second, these RNA sequences are fulllength mRNA molecules. Such a finding requires robust controls in order to qualify for these statements. Referee #3 similarly expressed this major concern. 1. The revised version does support the enrichment of spliced and polyadenylated sequences coding for Su(Hw) and CP190, but it does not support the statement that full length mRNA molecules are within these complexes.
Step-by-step conclusions: Fig.1 : RNA fragments (35 to 55 nt) enriched for Su(Hw) and CP190 exons are found. Therefore, there is no indication of a full-length transcript. Accordingly, any statement about fulllength mRNA molecules throughout the text has to be changed into something like "RNA sequences enriched for Su(Hw) and CP190 exons". 2. Functional concerns have been addressed convincingly.
Referee #3:
In my 1st review, I mentioned that "the recovery of the messenger RNAs encoding the proteins against which the antibodies used to perform the complex purification were directed is a conspicuous coincidence". This was also a concern for referee 2. The authors have made considerable efforts to argue against a possible caveat in their procedure and, as I already wrote in my initial review, I am willing to give the benefit of the doubt if the in vivo observations were solid state. Unfortunately, I remain uneasy about the conduction of the experiments dealing with the modulation of the enhancer blocking activity of the ct6 allele, and the paper cannot be published before the authors provide answers to the following questions. My concern stems from the fact that T7 polymerase expression in flies is toxic. This toxicity is very likely due to spurious transcription firing from cryptic promoters. The introduction of the T7-Su(HW) transgene (or T7-CP190) suppress this toxicity, giving rise to wings with normal morphology, but cuts in the wing margins. Suppression originates probably from a titration of the T7 polymerase that is now engaged on the T7 transgene. I am not convinced that these cuts are indeed due to the ct6 allele present in the background. Indeed, the blistered wings shown in Fig.S4C show interruptions in the wing margin (in the case of mod(mdg4)+ and no wing margin in mod(mdg4)u1. I would like to see as controls, wings with the T7 polymerase expressed under Ser-Gal4 in the presence of the T7-Su(Hw) or T7-CP190 in an otherwise WT background. Do these wings have perfect margins without any cuts? I would also like to see wings like the one shown in Fig.4F Cross-comments from referee 2:
As far as I can judge the suggestions of referee #3, the control in the background of WT flies and the use of the T7-mod(mdg4)2.2 control, which the authors have generated, but not used for wing analysis, seem to me very relevant and not to complicated to achieve: "I would like to see as controls, wings with the T7 polymerase expressed under Ser-Gal4 in the presence of the T7-Su(Hw) or T7-CP190 in an otherwise WT background. Do these wings have perfect margins without any cuts? I would also like to see wings like the one shown in Fig.4F but with the T7-mod(mdg4)2.2 as controls."
These indeed should be done to distinguish between general toxicity of T7-Su(Hw) or T7-CP190 and the postulated enhancer blocking activity. If the notching phenotype in the background of mod(mdg4)u1 is mediated by increased enhancer blocking, T7-Su(Hw) expression should have no effect in the wt background. Also, as suggested by referee #3, the T7-mod(mdg4)2.2 control should be tested in the background of mod(mdg4)u1.
Response to Editor and Referees
We appreciate the opportunity to revise the manuscript a second time. As requested by Referee #2, we have removed the claim that full-length mRNA transcripts are copurified with insulator complexes. Furthermore, we have addressed all of the concerns raised by Referee #3. While we agree that toxicity is observed when high levels of T7 polymerase are expressed in certain tissues, we observe no differences in imaginal wing disc development when T7 polymerase is expressed using Ser::Gal4. Furthermore, our data do not support the referee's suggestion that the presence of a T7 promoter transgene suppresses toxicity caused by T7 polymerase expression. Therefore, we do not believe that T7 polymerase "titration" by transgenes is a valid concern. Please find a detailed list of our responses to the Editor's and Referees' comments below. Editor Can you please add a scale bar to figure 4F, SF 4C and SF 5A?
We have added the requested scale bars. Since precise zoom levels were not recorded at the time of image collection, we estimated the size based on precise measurement of a wildtype wing. We have not observed any significant differences in overall wing size compared to wild type for any of the genotypes in our study. Referee #2 Accordingly, any statement about full--length mRNA molecules throughout the text has to be changed into something like "RNA sequences enriched for Su(Hw) and CP190 exons". We removed the term "full-length" from p. 7. Referee #3 My concern stems from the fact that T7 polymerase expression in flies is toxic. This toxicity is very likely due to spurious transcription firing from cryptic promoters. The introduction of the T7--Su(HW) transgene (or T7--CP190) suppress this toxicity, giving rise to wings with normal morphology, but cuts in the wing margins. Suppression originates probably from a titration of the T7 polymerase that is now engaged on the T7 transgene. We do not know the molecular mechanism behind the T7 polymerase toxicity, which is observed at high expression levels in certain tissues. Based on data shown in Fig. S4D , we do not observe that introduction of a T7 promoter-containing transgene necessarily suppresses toxicity. For example, in the mod(mdg4) u1 genetic background (the background in which the scoring in Fig. 4F is performed) , there is no obvious relationship between the presence of a T7 promoter-containing transgene and the extent of wing blistering. For example, expression of the T7-mod(mdg4)2.2 construct leads to a greater than two-fold increase in wing blistering compared to the no transgene control. In contrast, expression of the T7-su(Hw) construct leads to a greater than three-fold decrease in wing blistering compared to the no transgene control. I am not convinced that these cuts are indeed due to the ct6 allele present in the background. Indeed, the blistered wings shown in Fig.S4C show interruptions in the wing margin (in the case of mod(mdg4)+ and no wing margin in mod(mdg4)u1.
All of the wings shown in this study are of the ct 6 genotype. As we pointed out in the text on p. 11, it is very difficult to score the wing margin when strong blistering occurs. The referee's comment is a case in point. The images in Fig. S4C were rather difficult to obtain because wing expansion occurs during a brief window shortly after eclosion. Moreover, for blistered wings, the wing layers do not adhere properly after fluid release, and recognizable morphology is lost. Nevertheless, if one looks closely at these images, it is possible to see that there are interruptions in the wing margin of the mod(mdg4) + wings, as was noted by the reviewer. However, in the mod(mdg4)2.2 u1 wing, the margin, including bristles, is actually mainly intact (although distorted in the Z plane of the image due to blistering). Additional evidence for this conclusion is that it is also possible to see increased posterior tissue in the mod(mdg4)2.2 u1 compared to mod(mdg4) + wing. This obvious difference in wing margin morphology is undoubtedly due to the absence or presence of Mod(mdg4)2.2 protein, respectively, which is required for efficient enhancerblocking activity of the gypsy insulator. The strong suppression of ct 6 by mod(mdg4) u1 is well documented in the insulator literature; please see Capelson and Corces, 2005 for example. I would like to see as controls, wings with the T7 polymerase expressed under Ser--Gal4 in the presence of the T7--Su(Hw) or T7--CP190 in an otherwise WT background. Do these wings have perfect margins without any cuts? Unfortunately, we have not taken images of the wings mentioned above. We did routinely generate and examine flies of the four genotypes (no T7, T7-su(Hw), T7-Cp190, T7-mod(mdg4)2.2) in the ct + ; mod(mdg4) + background expressing T7 polymerase with Ser::Gal4. Similar to results shown in Fig. S4D for ct 6 flies, we also observed very high levels of blistering for these genotypes, which precluded quantitative analysis of the wing margin.
In order to address this concern, below we included images of non-blistered wings from the four genotypes in the ct 6 ; mod(mdg4) + background expressing T7 polymerase with Ser::Gal4 (as in Fig. S4D ). Based on the wings we were able to analyze, we do not observe significant differences in wing morphology when comparing these genotypes. Nor do we see significant differences for these genotypes compared to ct 6 flies expressing the Ser::Gal4 driver but not expressing T7 polymerase (not shown). These results suggest that expression of T7 polymerase does not substantially affect the cut wing phenotype. I would also like to see wings like the one shown in Fig.4F but with the T7--mod(mdg4)2.2 as controls. Are these wings of the ct6 type? As indicated in Fig. S4D , flies expressing T7-mod(mdg4)2.2 in the mod(mdg4)2.2 u1 background display extremely high levels of blistering (98%) and cannot be scored reliably for ct 6 . As stated previously, all wings scored in this study including Fig. 4F As mentioned previously, the use of P--elements to introduce the T7 transgenes is problematic because each line will have a different T7 polymerase titration effect and I would like to know how much variations in the cut phenotype one obtains with different insertions sites. It is thus important that the authors document the T7--mod(mdg4)2.2 control line with different insertions sites. As stated previously, we have no evidence for a T7 polymerase titration effect caused by the presence of T7 transgenes. As already stated in the Supplementary Methods, we did not observe any obvious differences in phenotype between at least two independent insertions of T7-su(Hw), T7-Cp190, and T7-mod(mdg4)2.2. Furthermore, as indicated in Fig. S4D , flies expressing T7-mod(mdg4)2.2 in the mod(mdg4)2.2 u1 background display extremely high levels of blistering (98%) and cannot be scored reliably for ct 6 . Finally I would like to know if the wings pictured in Fig4F are the wings of the genotype shown below or if they are just examples of variation in the ct phenotype. We added back the genotypes of the example wings to the Fig. 4F figure legend, which were removed from the previous submission due to space limitations. Cross--comments from referee 2 As far as I can judge the suggestions of referee #3, the control in the background of WT flies and the use of the T7--mod(mdg4)2.2 control, which the authors have generated, but not used for wing analysis, seem to me very relevant and not to complicated to achieve: "I would like to see as controls, wings with the T7 polymerase expressed under Ser--Gal4 in the presence of the T7--Su(Hw) or T7--CP190 in an otherwise WT background. Do these wings have perfect margins without any cuts? I would also like to see wings like the one shown in Fig.4F but with the T7--mod(mdg4)2.2 as controls." These indeed should be done to distinguish between general toxicity of T7--Su(Hw) or T7--CP190 and the postulated enhancer blocking activity. If the notching phenotype in the background of mod(mdg4)u1 is mediated by increased enhancer blocking, T7--Su(Hw) expression should have no effect in the wt background. Unfortunately, we have not taken images of the wings mentioned above. We did routinely generate and examine flies of the four genotypes (no T7, T7-su(Hw), T7-Cp190, T7-mod(mdg4)2.2) in the ct + ; mod(mdg4) + background expressing T7 polymerase with Ser::Gal4. Similar to results shown in Fig. S4D for ct 6 flies, we also observed very high levels of blistering for these genotypes, which precluded quantitative analysis of the wing margin. Also, as suggested by referee #3, the T7--mod(mdg4)2.2 control should be tested in the background of mod(mdg4)u1. As indicated in Fig. S4D , flies expressing T7-mod(mdg4)2.2 in the mod(mdg4)2.2 u1 background display extremely high levels of blistering (98%) and cannot be scored reliably for ct 6 .
3rd Editorial Decision 15 July 2013
We have now received the comments from referee 2 who is happy with the newly revised version and I am very pleased to accept your manuscript for publication in the next available issue of EMBO reports. Thank you for your contribution to our journal.
As part of the EMBO publication's Transparent Editorial Process, EMBO reports publishes online a Review Process File to accompany accepted manuscripts. As you are aware, this File will be published in conjunction with your paper and will include the referee reports, your point-by-point response and all pertinent correspondence relating to the manuscript.
If you do NOT want this File to be published, please inform the editorial office within 2 days, if you have not done so already, otherwise the File will be published by default [contact: emboreports@embo.org]. If you do opt out, the Review Process File link will point to the following statement: "No Review Process File is available with this article, as the authors have chosen not to make the review process public in this case."
Finally, we provide a short summary of published papers on our website to emphasize the major findings in the paper and their implications/applications for the non-specialist reader. To help us prepare this short, non-specialist text, we would be grateful if you could provide a simple 1-2 sentence summary of your article in reply to this email.
Thank you again for your contribution to EMBO reports and congratulations on a successful publication. Please consider us again in the future for your most exciting work.
